Postoperative Radiotherapy in Completely Resected Stage II and III Thymoma: How to Translate the Potential Survival Benefit in the Setting of the Future Adoption of the IASLC-ITMIG TNM-Based Staging System.

Related Articles

Postoperative Radiotherapy in Completely Resected Stage II and III Thymoma: How to Translate the Potential Survival Benefit in the Setting of the Future Adoption of the IASLC-ITMIG TNM-Based Staging System.

J Thorac Oncol. 2017 Jan;12(1):e8-e9

Authors: Basse C, Merveilleux du Vignaux C, Girard N

PMID: 27988104 [PubMed - in process]

http://ift.tt/2i21onq